Cargando…
Androgen receptor and its correlation with estrogen and progesterone receptors, aimed for identification of cases for future anti-androgen therapy in endometrial cancers
INTRODUCTION: The expression of androgen receptor (AR) is not commonly tested or studied in uterine cancers, unlike estrogen receptor (ER) and progesterone receptor (PR) which are positive in most endometrial carcinomas. In this series, we evaluated the expression of AR and its comparison to ER and...
Autores principales: | Moatamed, Neda A., Vahdatshariatpanahi, Saba, Gjertson, David W., Sachs, Chana R., Kang, Yuna, Ostrzega, Nora, Huang, Jiaoti, Memarzadeh, Sanaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508627/ https://www.ncbi.nlm.nih.gov/pubmed/37725629 http://dx.doi.org/10.1371/journal.pone.0291361 |
Ejemplares similares
-
The uterine pathological features associated with sentinel lymph node metastasis in endometrial carcinomas
por: Kang, Yuna, et al.
Publicado: (2020) -
Expression of Stromal Progesterone Receptor and Differential Methylation Patterns in the Endometrium May Correlate with Response to Progesterone Therapy in Endometrial Complex Atypical Hyperplasia
por: Neal, Adam S., et al.
Publicado: (2020) -
Membrane-Initiated Estrogen, Androgen, and Progesterone Receptor Signaling in Health and Disease
por: Mauvais-Jarvis, Franck, et al.
Publicado: (2021) -
Estrogen, Progesterone and Androgen Receptor in Primary and Recurrent Pleomorphic Salivary Adenomas
por: Tarakji, Bassel, et al.
Publicado: (2023) -
SUN-352 Estrogen, Progesterone, and Androgen Receptor Expressions Predict the Prognosis for Adrenocortical Carcinoma
por: Oguz, Seda, et al.
Publicado: (2019)